Global Stereotactic Biopsy Tables Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Technology;
Mechanically Operated, and Electronically Operated.By Application;
Vacuum-assisted Core Biopsy, and Core-needle Aspiration.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Stereotactic Biopsy Tables Market (USD Million), 2021 - 2031
In the year 2024, the Global Stereotactic Biopsy Tables Market was valued at USD 173.21 million. The size of this market is expected to increase to USD 260.45 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.
The Global Stereotactic Biopsy Tables Market encompasses a wide array of sophisticated medical equipment designed to facilitate minimally invasive biopsy procedures with precision and accuracy. These specialized tables serve as crucial tools in the diagnosis and treatment of various medical conditions, particularly in the field of oncology. Stereotactic biopsy tables offer healthcare professionals the capability to perform tissue sampling from target lesions with unparalleled accuracy, guided by advanced imaging technologies such as MRI, CT, or ultrasound. This precision is essential in obtaining high-quality tissue samples for histopathological analysis, aiding in the early detection and characterization of tumors, as well as guiding treatment decisions for optimal patient outcomes.
As the demand for minimally invasive diagnostic procedures continues to rise, driven by factors such as increasing cancer prevalence and advancements in imaging technology, the global stereotactic biopsy tables market is witnessing significant growth. Healthcare facilities worldwide are investing in state-of-the-art stereotactic biopsy tables to enhance their diagnostic capabilities and improve patient care. Ongoing research and development efforts are focused on refining existing technologies and introducing innovative features to further enhance the precision, efficiency, and patient comfort associated with stereotactic biopsy procedures. With a growing emphasis on early disease detection and personalized medicine, the global stereotactic biopsy tables market is poised for continued expansion, offering healthcare providers invaluable tools to meet the evolving needs of patients and improve overall diagnostic accuracy and treatment outcomes.
Global Stereotactic Biopsy Tables Market Recent Developments
-
In January 2023, Becton, Dickinson, and Company, one of the major medical technology organizations, introduced a new robotic track system for the BD Kiestra microbiology laboratory solution. This innovative system enables automated specimen processing in laboratory settings.
-
In 2020, North America held the major share in terms of revenue in the global breast biopsy market, and the region is also projected to maintain its dominance during the forecast period from 2021 to 2030. The region has a potential medical tourism market, which additionally supports the dominating regional market value.
Segment Analysis
The Global Stereotactic Biopsy Tables Market is segmented by technology into mechanically operated and electronically operated systems. Mechanically operated biopsy tables offer reliability and simplicity in their operation, providing precise positioning for biopsy procedures. These tables are manually adjustable, allowing healthcare professionals to position patients accurately for vacuum-assisted core biopsy or core-needle aspiration procedures. Electronically operated biopsy tables feature advanced automation and digital controls, enabling precise and effortless positioning with programmable settings. These tables enhance workflow efficiency and operator comfort, facilitating streamlined biopsy procedures and improving patient experience during image-guided interventions.
In terms of application, the market is categorized into vacuum-assisted core biopsy and core-needle aspiration techniques. Vacuum-assisted core biopsy systems allow for the collection of tissue samples with minimal trauma and increased accuracy, making them suitable for diagnosing breast abnormalities and other soft tissue lesions. Core-needle aspiration techniques utilize fine-gauge needles to extract tissue samples from deeper anatomical structures, providing diagnostic insights into various conditions such as lung nodules and abdominal masses. The availability of stereotactic biopsy tables tailored to these specific applications enhances procedural precision and diagnostic yield, contributing to improved patient outcomes and healthcare provider efficiency. The market spans North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America, with each region witnessing varying levels of adoption and technological advancements in stereotactic biopsy table systems to meet the growing demand for minimally invasive biopsy procedures across diverse healthcare settings.
Global Stereotactic Biopsy Tables Segment Analysis
In this report, the Global Stereotactic Biopsy Tables Market has been segmented by Technology, Application, and Geography.
Global Stereotactic Biopsy Tables Market, By Technology
The Global Stereotactic Biopsy Tables Market has been segmented by Technology into Mechanically Operated and Electronically Operated.
Mechanically operated stents rely on physical mechanisms, such as balloon inflation or self-expansion, to deploy and conform to the dimensions of the target vessel. These stents are often made of metallic alloys or polymers with shape memory properties, allowing them to maintain structural integrity while exerting radial force against arterial walls. Mechanically operated stents are particularly suited for treating focal lesions or stenotic segments in coronary arteries, where precise placement and immediate expansion are critical for restoring blood flow and maintaining vessel patency. Their simplicity and reliability make them a preferred choice in many clinical scenarios, providing effective support for diseased arteries and facilitating minimally invasive procedures with high success rates.
Electronically operated stents incorporate advanced technologies, such as sensors, actuators, and microelectronics, to enhance stent performance and functionality. These stents offer dynamic adjustability and real-time monitoring capabilities, allowing for personalized treatment approaches and adaptive responses to changing physiological conditions. Electronically operated stents may incorporate features such as drug delivery systems, biometric sensors, or remote monitoring capabilities, enabling healthcare providers to optimize treatment outcomes and improve patient management strategies. While the complexity and cost of electronically operated stents present challenges in widespread adoption, ongoing research and development efforts aim to harness the full potential of these innovative devices in addressing complex cardiovascular diseases and advancing precision medicine approaches in interventional cardiology.
Global Stereotactic Biopsy Tables Market, By Application
The Global Stereotactic Biopsy Tables Market has been segmented by Application into Vacuum-assisted Core Biopsy and Core-needle Aspiration.
Vacuum-assisted Core Biopsy involves the use of a specialized biopsy table equipped with stereotactic guidance to precisely target and extract tissue samples from suspicious breast lesions. This technique offers several advantages over traditional biopsy methods, including improved accuracy, reduced procedure time, and minimal patient discomfort. By utilizing vacuum pressure to facilitate tissue collection, vacuum-assisted core biopsy allows for larger tissue samples to be obtained, enhancing diagnostic yield and enabling comprehensive histopathological analysis for accurate diagnosis and treatment planning in cases of breast cancer and other breast abnormalities.
Core-needle Aspiration is another key application of Stereotactic Biopsy Tables, involving the percutaneous extraction of tissue samples using a hollow needle guided by stereotactic imaging. This minimally invasive procedure enables the sampling of lesions located deep within the breast tissue or other anatomical sites with high precision and minimal trauma to surrounding structures. Core-needle Aspiration is commonly employed in the diagnosis of breast lesions, thyroid nodules, and other soft tissue abnormalities, providing valuable diagnostic information while avoiding the need for more invasive surgical procedures.
Global Stereotactic Biopsy Tables Market, By Geography
In this report, the Global Stereotactic Biopsy Tables Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Stereotactic Biopsy Tables Market Share (%), by Geographical Region, 2024
North America, comprising the United States and Canada, emerges as a significant market contributor driven by advanced healthcare infrastructure and a high prevalence of breast cancer cases prompting demand for diagnostic tools like stereotactic biopsy tables. The region benefits from extensive adoption of advanced medical technologies and innovative healthcare practices, fostering the growth of the stereotactic biopsy tables market. Robust reimbursement policies and increasing investments in healthcare further support market expansion in North America, as healthcare facilities strive to enhance diagnostic accuracy and improve patient outcomes. In Europe, countries such as Germany, the United Kingdom, and France play pivotal roles in driving market growth for stereotactic biopsy tables. The region witnesses rising incidences of breast cancer and other malignancies, necessitating efficient diagnostic solutions for early detection and treatment planning.
Favorable government initiatives aimed at improving cancer care and enhancing healthcare infrastructure contribute to the market's momentum in Europe. Strategic collaborations between medical device manufacturers and healthcare providers facilitate technological advancements and the development of innovative stereotactic biopsy table solutions tailored to meet the specific needs of European healthcare systems. The Asia Pacific region presents lucrative growth opportunities for the stereotactic biopsy tables market, fueled by increasing healthcare expenditure, expanding patient population, and rising awareness about the importance of early cancer detection and diagnosis. Emerging economies in the Middle East and Africa, as well as Latin America, are also witnessing steady market growth driven by efforts to address the growing burden of cancer and improve access to advanced diagnostic technologies.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Stereotactic Biopsy Tables Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- More cancer screening
- Improved biopsy accuracy
- Awareness of early cancer detection
-
Ergonomic biopsy tables - Ergonomic biopsy tables are designed to enhance comfort and efficiency during biopsy procedures, benefiting both patients and healthcare professionals. These tables feature adjustable height, tilt, and positioning options to accommodate various body types and procedural requirements, reducing strain and fatigue for clinicians.
Ergonomic design elements such as padded armrests, contoured surfaces, and easy-to-reach controls optimize patient comfort and relaxation during the procedure, improving overall satisfaction and compliance. By promoting better ergonomics, these tables contribute to a more ergonomic work environment for healthcare providers, reducing the risk of musculoskeletal injuries and enhancing procedural precision and accuracy.
Restraints
- Technology adoption hesitancy
- Imaging integration difficulties
-
Result interpretation variability - Result interpretation variability refers to differences in how biopsy results are interpreted by healthcare professionals, which can impact diagnostic accuracy and patient management decisions. Factors contributing to interpretation variability may include subjective assessment criteria, variations in observer expertise and experience, and differences in imaging modalities and protocols.
To mitigate interpretation variability, standardization of biopsy protocols, ongoing training and education for interpreting clinicians, and the use of advanced imaging techniques such as digital pathology and artificial intelligence can be implemented. Interdisciplinary collaboration among radiologists, pathologists, and treating physicians can facilitate consensus-driven interpretation and enhance diagnostic reliability and confidence.
Opportunities
- Cloud imaging adoption
- Genetic-based biopsies
- Public-private cancer programs
-
Mobile, portable tables - Mobile and portable biopsy tables offer flexibility and versatility in healthcare settings, enabling clinicians to perform procedures in various locations such as outpatient clinics, ambulatory surgical centers, and remote healthcare facilities. These tables are designed to be lightweight, compact, and easily transportable, facilitating seamless integration into different environments and enhancing procedural accessibility for patients.
Mobile and portable tables often feature collapsible or foldable designs for convenient storage and transportation, making them ideal for settings with limited space or resource constraints. By enabling healthcare providers to bring biopsy services closer to patients, mobile and portable tables promote greater patient convenience, timeliness of care, and overall healthcare accessibility, particularly in underserved or remote communities.
Competitive Landscape Analysis
Key players in Global Stereotactic Biopsy Tables Market include
- MPI Medical Inc.
- Devicor Medical Products
- Hologic
- Aurora Imaging Technology
- Planmed Oy
- Metaltronica and others.
- Siemens AG
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By Region
- Global Stereotactic Biopsy Tables Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- More cancer screening
- Improved biopsy accuracy
- Awareness of early cancer detection
- Ergonomic biopsy tables
- Restraints
- Technology adoption hesitancy
- Imaging integration difficulties
- Result interpretation variability
- Opportunities
- Cloud imaging adoption
- Genetic-based biopsies
- Public-private cancer programs
- Mobile, portable tables
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Stereotactic Biopsy Tables Market, By Technology, 2021 - 2031 (USD Million)
- Mechanically Operated
- Electronically Operated
- Global Stereotactic Biopsy Tables Market, By Application, 2021 - 2031 (USD Million)
- Vacuum-assisted Core Biopsy
- Core-needle Aspiration
- Global Stereotactic Biopsy Tables Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Stereotactic Biopsy Tables Market, By Technology, 2021 - 2031 (USD Million)
- Competitive Landscape Analysis
- Company Profiles
- MPI Medical Inc.
- Devicor Medical Products
- Hologic
- Aurora Imaging Technology
- Planmed Oy
- Metaltronica and others.
- Siemens AG
- Company Profiles
- Analyst Views
- Future Outlook of the Market